December 15, 2016 / 11:18 PM / in a year

BRIEF-Acerus announces NATESTO license agreement with Hyundai Pharm

Dec 15 (Reuters) - Acerus Pharmaceuticals Corporation :

* Acerus pharmaceuticals corporation- acerus is eligible to receive a milestone payment upon regulatory approval of natesto in south korea

* Acerus pharmaceuticals corporation - will receive non-refundable upfront fee, with a first instalment paid at signing and remaining payable in jan 2017

* Acerus pharmaceuticals corporation- acerus will oversee manufacturing of natesto and receive a supply price for product

* Press release - acerus announces natesto license agreement with hyundai pharm Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below